Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle.
Division of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: cdefilip@medicine.umaryland.edu.
Christopher R
CR
deFilippi
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
Robert H
RH
Christenson
D017079:Exercise Tolerance / Q000502:physiology*; D005260:Female; D037502:Galectin 3 / Q000097:blood*; D054144:Heart Failure, Diastolic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D013318:Stroke Volume / Q000502:physiology*; D016277:Ventricular Function, Left / Q000502:physiology*
D037502:Galectin 3; D058986:Phosphodiesterase 5 Inhibitors
cardiac biomarker; ejection fraction; galectin-3; renal function